Tiankang (301263.SZ) subsidiary received the acceptance notification letter for the registration of Lidocaine Prilocaine Cream pharmaceutical product.

Wisdom Financial News APP, Tiancong (301263.SZ) announced that its wholly-owned subsidiary, Guangdong Tiancong Pharmaceutical Factory Co., Ltd., recently received the "Acceptance Notice" for the registration and listing application of Lidocaine Prilocaine Cream for domestic production medicine issued by the National Medical Products Administration (referred to as "NMPA"). According to the provisions of Article 32 of the Administrative Licensing Law of the People's Republic of China, the NMPA has reviewed the application for registration and listing of the above-mentioned medicine and has decided to accept it.